The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2023 | Real-world treatment patterns & outcomes among patients with triple-class exposed myeloma
In this video, Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ, shares some insights into a real-world study which evaluated treatment outcomes among patients with triple-class exposed (TCE) multiple myeloma, and further comments on the importance of conducting further studies like this to understand how the implementation of immunotherapies may play a role. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
